Nanobiotix Newswire

Comprehensive Real-Time News Feed for Nanobiotix.

Results 1 - 20 of 34 in Nanobiotix

  1. Cancer Nanomedicine Marketplace Discussed by Kuick Research in...Read the original story w/Photo

    17 hrs ago | PRWeb

    ... m Pharmaceuticals, Access Pharmaceuticals, Bind Biosciences, Samyang, Arrowhead Research, Epeius Biotechnologies, Nanobiotix, Nippon Kayaku, NanoCarrier, and Takeda Pharmaceutical.

    Comment?

  2. PharmaEngine, Inc. (4162) - Financial and Strategic SWOT Analysis Review - New Market ReportRead the original story

    23 hrs ago | PR-inside.com

    ... the treatment of metastatic pancreatic cancer. The company is partnered with Merrimack Pharmaceuticals, Inc., and Nanobiotix S.A. It has research and development facility. The company has collaboration with Guangzhou BeBetter Medicine Technology ...

    Comment?

  3. Nanobiotix 2014 Q4 And Annual RevenuesRead the original story

    Thursday Feb 26 | BioSpace

    Paris, France, 27 February, 2015 - NANOBIOTIX - a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, today announces its revenues for Q4 and the annual revenues for the year ended December 31, 2014. Activity Nanobiotix revenues for the fourth quarter of 2014 include the upfront payment from the Taiwan-based PharmaEngine within the framework of the licensing contract signed in August 2012.

    Comment?

  4. Prasad receives first Innovation Impact AwardRead the original story w/Photo

    Thursday Feb 26 | UB Reporter

    ... and laser-activated nanoparticles for cancer diagnosis and treatment. This technology was licensed to UB spinoff Nanobiotix, a French publicly traded company and leader in nanomedicine that has maintained close contact with Prasad while working to ...

    Comment?

  5. New Market Research Report: Nanobiotix - Product Pipeline Review - 2014Read the original story

    Monday Feb 23 | PR-inside.com

    This report provides comprehensive information on the current therapeutic developmental pipeline of Nanobiotix's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action , route of administration and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

    Comment?

  6. Professor Joins Nanobiotix As Scientific AdvisorRead the original story

    Thursday Feb 19 | BioSpace

    NANOBIOTIX , a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced that Professor Robert Langer, Institute Professor at the Massachusetts Institute of Technology , has become Scientific Advisor to Nanobiotix. Laurent Levy, CEO of Nanobiotix, commented: " We really appreciate that Professor Langer joined us as a Scientific Advisor.

    Comment?

  7. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Thursday Feb 19 | Business Wire

    ... a celle piccole, ha annunciato in data odierna che Warid Telecom, un operatore pakistano ... )--Regulatory News: NANOBIOTIX (Paris:NANO) (Euronext : NANO - ISIN: FR0011341205), sociA tA franA aise pionniA re en nanomA decine ...

    Comment?

  8. Professor Robert Langer joins Nanobiotix as Scientific AdvisorRead the original story

    Thursday Feb 19 | PR-inside.com

    Small but heading for the big time Professor Robert Langer joins Nanobiotix as Scientific Advisor Paris, France, 19 February, 2015 - NANOBIOTIX , a late clinical-stage nanomedicine company pioneering novel approaches for the local treatment of cancer, announced that Professor Robert Langer, Institute Professor at the Massachusetts Institute of Technology , has become Scientific Advisor to Nanobiotix. Laurent Levy, CEO of Nanobiotix, commented: "We really appreciate that Professor Langer joined us as a Scientific Advisor.

    Comment?

  9. NDDS in Cancer Therapy Market is expected to reach USD 15.9 billion in 2020Read the original story w/Photo

    Feb 2, 2015 | PRWeb

    ... in enhanced performance by the devices and are ultimately driving market growth by their increased adoption. Nanobiotix, a nanomedicine company focused on oncology, is developing NanoXray particles with the intent to enhance dose and efficacy of ...

    Comment?

  10. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Jan 27, 2015 | Business Wire

    The Company posted record quarterly revenue of $74.6 billion ... )--Rabobank, the world's premier bank to the food, beverage and agribusiness industry, and SF New Tech, San Francisco's largest and longest-running tech show... )--ESB Financial Corporation , the parent company of ESB Bank, today announced earnings of $1.02 per diluted share on net income of $18.2 million for ... )--Apartment Investment and Management Company announced today that its Board of Directors declared a quarterly cash dividend of $0.28 per share of Class... )--Regulatory News: NANOBIOTIX , sociA tA franA aise pionniA re en nanomA decine dA veloppant NanoXray, une approche thA rapeutique rA volutionna... )--The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other vi... )--After a ... (more)

    Comment?

  11. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Jan 27, 2015 | Business Wire

    ... that its Board of Directors declared a quarterly cash dividend of $0.28 per share of Class... )--Regulatory News: NANOBIOTIX (Euronext : NANO - ISIN: FR0011341205), sociA tA franA aise pionniA re en nanomA decine dA veloppant ...

    Comment?

  12. Carbon nanotube maker Bio-Pact moves HQ from Arizona to CambridgeRead the original story w/Photo

    Jan 7, 2015 | Business Journal

    ... but today the company announced it will be based at 245 First St. in Cambridge. Among the others Patrick met is Nanobiotix, which announced last September it would move to Boston, and the other three are still considering coming to the state, ...

    Comment?

  13. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Jan 7, 2015 | Business Wire

    Nanobiotix 2014 Review, 2015 Anticipated Milestones and Financial Calendar Nanobiotix Moved up to a New Level: Major Clinical and Financial Progress, Broadening of Indications and Strategic Plans To Develop across Europe, Asia and the US )--Regulatory News: NANOBIOTIX , a late clinical-stage nanomedicine company pioneering novel approaches for the local treatmen... Finnair Signed a Letter of Intent: Staffpoint and GWS to Become Shareholders in a Joint Venture Focused on Regional Flying )--Regulatory News: Finnair has signed a letter of intent with StaffPoint Holding Ltd and G.W. Sohlberg Ltd., in accordance with which Flybe UK Ltd's 60 % owners... )--Regulatory News: Skanska Skanska has signed a contract with NYU Langone Medical Center to build a new medical center in New York City.

    Comment?

  14. Report Published: "Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014"Read the original story

    Dec 28, 2014 | PR-inside.com

    ... Santaris Pharma A/S, CEL-SCI Corporation, OXiGENE, Inc., Takara Bio Inc., Panacea Biotec Limited, PCI Biotech AS, Nanobiotix, Acceleron Pharma, Inc., Virttu Biologics Limited, Ascenta Therapeutics,

    Comment?

  15. New Market Research Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014Read the original story

    Dec 17, 2014 | PR-inside.com

    ... Santaris Pharma A/S, CEL-SCI Corporation, OXiGENE, Inc., Takara Bio Inc., Panacea Biotec Limited, PCI Biotech AS, Nanobiotix, Acceleron Pharma, Inc., Virttu

    Comment?

  16. Nanobiotix Places Shares And Warrants With U.S. InvestorRead the original story

    Nov 30, 2014 | BioSpace

    NANOBIOTIX , a clinical-stage French nanomedicine company working on the local treatment of cancer, and listed on Euronext, Paris, announced the completion of a private placement on November 24, 2014.

    Comment?

  17. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Dec 1, 2014 | Business Wire

    Hostess Brands Invites Fans to Join the Sweetest Mission Ever and Celebrate the Penguins of Madagascar Release with Operation Hostess Holiday Sweepstakes )--Hostess Introduces Gingerbread Spice Donettes for a Limited Time in Packaging Featuring the Penguins of Madagascar; Fans Can Win a Grand Prize Trip to D.C., or a ... )--As Agent Bank, please be advised of the following rate determined on: 12/1/2014 Issue A Bluestone Securities plc - Series 2005-01 GBP 94,500,000 Class A Notes due 01 Jun 20... )--Regulatory News: Solteq In the NASDAQ OMX Helsinki Trade date 1.12.2014 Bourse trade Buy Share STQ1V Amount 1000 Shares Total cost 1 430,00 EUR Average pric... )--Viscount Systems , a leading provider of IT-based security software and services, has been recognized by Government Security News as a winn... )--Regulatory News: NANOBIOTIX , sociA tA franA aise pionniA re en ... (more)

    Comment?

  18. New Market Research Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2014Read the original story

    Nov 10, 2014 | PR-inside.com

    ... Santaris Pharma A/S, CEL-SCI Corporation, OXiGENE, Inc., Takara Bio Inc., Panacea Biotec Limited, PCI Biotech AS, Nanobiotix, Acceleron Pharma, Inc., Virttu Biologics Limited, Ascenta Therapeutics, Inc., Onconova Therapeutics, Inc.

    Comment?

  19. Press release distribution, EDGAR filing, XBRL, regulatory filingsRead the original story

    Nov 5, 2014 | Business Wire

    ... film it? Des Moines-based financial professional, Jenny Smith, found out firs... )--Regulatory News: Nanobiotix (Paris:NANO): Place de cotation : Euronext Paris de Nyse Euronext Compartiment : Compartiment C Code ISIN : FR0011341205 Site web : ...

    Comment?

  20. Experts cautious over Google...Read the original story w/Photo

    Oct 29, 2014 | Bangkok Post

    ... stroke or heart attack. "The idea isn't new," said Laurent Levy, founder and chairman of a French company, Nanobiotix, which is looking at the use of nanoparticles in cancer radiotherapy. "It's not science fiction -- it is achievable," he told AFP, ...

    Comment?